Program
lisdexamfetamine
Also written as “SPD489”, “NRP104” and “SPD489 (Lisdexamfetamine dimesylate)”.
Its studies are mostly in Attention Deficit Disorder with Hyperactivity · Schizophrenia · Depressive Disorder, Major · Binge-Eating Disorder · Sleep Deprivation, led by 3 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Takeda | 450 open or running | phase 4since Jul 10, 2007 | Oct 31, 2005 | none ahead |
| Humanis Saglık Anonim Sirketi | 10 open or running | phase 1since Jul 25, 2025 | Jul 25, 2025 | none ahead |
| Knoa Pharma | 10 open or running | phase 3since Aug 28, 2015 | Aug 28, 2015 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 30 studies since Oct 31, 2005.
- Sep 15, 2011Phase 2 study in Depressive Disorder, MajorTakeda · NCT01435759 · 1,197 enrolled · United States, Argentina, Australia and more
- Oct 19, 2011Phase 1 study in SchizophreniaTakeda · NCT01457339 · 31 enrolled · United States
- Mar 6, 20122 phase 4 studies in Attention Deficit Disorder with HyperactivityTakeda · NCT01552915, NCT01552902
- Aug 1, 2012Phase 3 study in Binge-Eating DisorderTakeda · NCT01657019 · 604 enrolled · United States, Germany, Spain
- Oct 29, 20122 phase 3 studies in Binge-Eating DisorderTakeda · NCT01718509, NCT01718483
- Nov 28, 2012Phase 3 study in SchizophreniaTakeda · NCT01738698 · 4 enrolled · United States
- Jan 2, 20132 phase 3 studies in SchizophreniaTakeda · NCT01760993, NCT01760889
- Jun 27, 2013Phase 1 study in Healthy VolunteersTakeda · NCT01890785 · 30 enrolled · United States
- Dec 6, 2013Phase 3 study in Binge-Eating DisorderTakeda · NCT02009163 · 418 enrolled · United States, Canada, Germany and more
- Mar 19, 2015Phase 2 study in Attention Deficit Disorder with HyperactivityTakeda · NCT02402166 · 24 enrolled · United States
- Jun 4, 2015Phase 3 study in Attention Deficit Disorder with HyperactivityTakeda · NCT02466386 · 113 enrolled · United States
- Aug 28, 2015Knoa Pharma's first study: phase 3 study in Attention Deficit Disorder with HyperactivityNew to Knoa PharmaKnoa Pharma · NCT02555150 · 40 enrolled · United States
- Aug 9, 2017Phase 3 study in Attention Deficit Disorder with HyperactivityTakeda · NCT03260205 · 199 enrolled · United States
- Jul 25, 2025Humanis Saglık Anonim Sirketi's first study: phase 1 study in Attention Deficit Disorder with HyperactivityNew to Humanis Saglık Anonim SirketiHumanis Saglık Anonim Sirketi · NCT07098585 · 48 enrolled · India
TargetBeta
“Dopamine transporter releasing agent; Norepinephrine transporter releasing agent; Synaptic vesicular amine transporter inhibitor”ChEMBL 37, by rule
Studies
All 47 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07098585Attention Deficit Disorder with Hyperactivity · India | 1 | Completed | Humanis Saglık Anonim Sirketi | Jun 6, 2025 | 48 |
| NCT03260205Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | Oct 23, 2018 | 199 |
| NCT02555150Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Knoa Pharma | Jan 2017 | 40 |
| NCT02466386Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | Jan 3, 2020 | 113 |
| NCT02402166Attention Deficit Disorder with Hyperactivity · United States | 2 | Completed | Takeda | Jun 30, 2016 | 24 |
| NCT02009163Binge-Eating Disorder · United States, Canada, Germany and more | 3 | Completed | Takeda | Apr 8, 2015 | 418 |
| NCT01890785Healthy Volunteers · United States | 1 | Completed | Takeda | Aug 22, 2013 | 30 |
| NCT01760993Schizophrenia · United States | 3 | Terminated | Takeda | Apr 1, 2013 | 2 |
| NCT01760889Schizophrenia · United States | 3 | Terminated | Takeda | Apr 1, 2013 | 1 |
| NCT01738698Schizophrenia · United States | 3 | Terminated | Takeda | Apr 1, 2013 | 4 |
| NCT01718509Binge-Eating Disorder · United States, Germany | 3 | Completed | Takeda | Sep 20, 2013 | 390 |
| NCT01718483Binge-Eating Disorder · United States, Germany, Spain and more | 3 | Completed | Takeda | Sep 25, 2013 | 383 |
| NCT01657019Binge-Eating Disorder · United States, Germany, Spain | 3 | Completed | Takeda | Oct 21, 2014 | 604 |
| NCT01552915Attention Deficit Disorder with Hyperactivity · United States | 4 | Completed | Takeda | Jan 22, 2014 | 464 |
| NCT01552902Attention Deficit Disorder with Hyperactivity · United States, Canada, Germany and more | 4 | Completed | Takeda | May 22, 2014 | 549 |
| NCT01457339Schizophrenia · United States | 1 | Completed | Takeda | Jan 20, 2012 | 31 |
| NCT01436175Depressive Disorder, Major · United States, Canada, Chile and more | 3 | Terminated | Takeda | Mar 27, 2014 | 1,570 |
| NCT01436162Depressive Disorder, Major · United States, Belgium, Czechia and more | 3 | Completed | Takeda | Dec 10, 2013 | 1,105 |
| NCT01436149Depressive Disorder, Major · United States, Canada, Croatia and more | 3 | Completed | Takeda | Dec 23, 2013 | 1,262 |
| NCT01435759Depressive Disorder, Major · United States, Argentina, Australia and more | 2 | Completed | Takeda | Jan 17, 2014 | 1,197 |
| NCT01328756Attention Deficit Disorder with Hyperactivity · Belgium, Germany, Hungary and more | 4 | Completed | Takeda | Sep 30, 2014 | 314 |
| NCT01291173Binge-Eating Disorder · United States | 2 | Completed | Takeda | Jan 30, 2012 | 271 |
| NCT01274221Attention Deficit Disorder with Hyperactivity · United States | 3 | Withdrawn | Takeda | May 4, 2011 | 0 |
| NCT01234298Negative Symptoms of Schizophrenia | 3 | Withdrawn | Takeda | Feb 24, 2014 | 0 |
| NCT01106430Attention Deficit Disorder with Hyperactivity · United States, Belgium, Canada and more | 3 | Completed | Takeda | Jul 19, 2012 | 267 |
| NCT01101022ADHD Specifically With Executive Function Impairment · United States | 4 | Completed | Takeda | Nov 29, 2010 | 161 |
| NCT01096680Sleep Deprivation · United States | 2 | Completed | Takeda | Jul 18, 2010 | 135 |
| NCT01010750Attention Deficit Disorder with Hyperactivity · United States | 1 | Completed | Takeda | Mar 28, 2010 | 18 |
| NCT00985725Depressive Disorder, Major · United States | 2 | Completed | Takeda | Apr 18, 2011 | 143 |
| NCT00922272Schizophrenia · United States | 2 | Completed | Takeda | Jan 20, 2011 | 92 |
| NCT00919867Healthy · United States | 1 | Completed | Takeda | Jul 30, 2009 | 42 |
| NCT00905424Depressive Disorder, Major · United States | 2 | Completed | Takeda | Aug 4, 2010 | 246 |
| NCT00877487Attention Deficit Disorder with Hyperactivity · United States | 4 | Completed | Takeda | Jul 8, 2010 | 123 |
| NCT00784654Attention Deficit Disorder with Hyperactivity · United States, Belgium, France and more | 3 | Completed | Takeda | Oct 26, 2011 | 276 |
| NCT00776555Healthy · United States | 1 | Terminated | Takeda | Mar 31, 2009 | 3 |
| NCT00763971Attention Deficit Disorder with Hyperactivity · Belgium, France, Germany and more | 3 | Completed | Takeda | Mar 16, 2011 | 336 |
| NCT00764868Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | Apr 22, 2010 | 269 |
| NCT00746733Healthy Volunteers · United States | 1 | Completed | Takeda | Oct 26, 2008 | 24 |
| NCT00735371Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | Apr 6, 2009 | 314 |
| NCT00557011Attention Deficit Disorder with Hyperactivity | 2 | Completed | Takeda | 52 | |
| NCT00556296Attention Deficit Disorder with Hyperactivity | 3 | Completed | Takeda | 297 | |
| NCT00500149Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | Dec 5, 2007 | 129 |
| NCT00500071Attention Deficit Disorder with Hyperactivity · United States | 4 | Completed | Takeda | Jan 2, 2008 | 318 |
| NCT00337285Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | Nov 2007 | 349 |
| NCT00334880Attention Deficit Disorder with Hyperactivity · United States | 3 | Completed | Takeda | 420 | |
| NCT00248092Attention Deficit Disorder with Hyperactivity · United States | 2 | Completed | Takeda | 36 | |
| NCT00247572Attention Deficit Disorder with Hyperactivity · United States | 2 | Completed | Takeda | 12 |
How it is read
Names in the registry
- “SPD489”, 6 entries
- “NRP104”, 6 entries
- “SPD489 (Lisdexamfetamine dimesylate)”, 5 entries
- “Lisdexamfetamine dimesylate”, 5 entries
- “Lisdexamfetamine Dimesylate”, 4 entries
Conditions, from the studies’ own filings
- Attention Deficit Disorder with Hyperactivity, 25 studies
- Schizophrenia, 6 studies
- Depressive Disorder, Major, 6 studies
- Binge-Eating Disorder, 5 studies
- Sleep Deprivation, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.